Hyperinsulinemia and deregulated insulin signaling occur in obesity, type 2 diabetes and NAFLD, and insulin activates PI3K/Akt signaling, a key regulator of metabolism, cell growth and cell survival. The gene discussed is AKT1; the disease is obesity disorder.